Market Overview

UPDATE: ISI Group Upgrades Cardinal Health to Overweight; Pricing Fears Overdone

Related CAH
Who Will Feel The Pain From Generic Drug Price Inflation?
#PreMarket Primer: Friday, October 31: BOJ Spooked By Lackluster Growth And Inflation

ISI Group raised its rating on Cardinal Health (NYSE: CAH) from Market Weight to Overweight and increased its price target from $45 to $46.

ISI Group noted, "We believe that fears over pricing on the upcoming WAG and CVS contracts are overwrought by investors and overpriced in CAH shares. At ~6x EV/EBITDA, CAH offers investors ~9% FCF yield (ex one-time items) and high-single-digit EPS growth in the medium-term with downside already baked in to expectations (~3-5% hit to EPS from re-pricing pressures with cost leverage to cushion)."

Cardinal Health closed at $40.85 on Monday.

Latest Ratings for CAH

DateFirmActionFromTo
Nov 2014BarclaysMaintainsOverweight
Oct 2014CitigroupMaintainsNeutral
Oct 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for CAH
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (CAH)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional